✦ LIBER ✦

Multiple pulmonary lesions in a patient treated with BCNU (1,3-BIS(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme

✍ Scribed by Peter A. Bellot; Ronald O. Valdiserri

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 568 KB
Volume: 43
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197901)43:1<46::aid-cncr2820430106>3.0.co;2-c

No coin nor oath required. For personal study only.

✦ Synopsis

A patient with a glioblastoma multiforme who was treated with BCNU, developed rapidly progressive pulmonary disease. The pulmonary changes were studied pathologically and included atypical alveolar cell hyperplasia, hyaline membranes, and interstitial fibrosis. These lesions contributed to the patient's demise and may be related to the administration of BCNU.

📜 SIMILAR VOLUMES

Adriamycin, 1,3-bis (2-chloroethyl)-1-ni

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962), cyclophosphamide plus prednisone (ABC-P) in melphalan-resistant multiple myeloma

✍ Cary A. Presant; Carol Klahr 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 1 views

Phase II study of 1,3-Bis (2-chloroethyl

Phase II study of 1,3-Bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC #409962) with amphotericin B in bronchogenic carcinoma

✍ Cary A. Presant; Stephen Hillinger; Carol Klahr 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

Eighteen patients with unresectable bronchogenic carcinoma were treated with amphotericin B (7.5 mgim' on day I , I5 mg/m2 on day 2, and 30 mg/m2 on days 3 and 4) plus BCNU (250 mg/m2 on day 4 following amphotericin B) with courses of therapy repeated every 8 weeks. All patients had metastatic disea

Phase I evaluation of the combination 1,

Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases

✍ Creagan, Edward T. ;Eagan, Robert T. ;Rubin, Joseph 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB